Issues to Address and Continuation of Research and Development Activities
First written in FY2017-Q1. 15 of 33 entries say "Restated". Latest entry: FY2026.
31 other companies' latest entry also says "Other".
- FY2026Slight decline in R&D expensesAnnual report
「The total amount of research and development expenses for the consolidated fiscal year was ¥41.496 million.」
Research and development activities continued, but research and development expenses decreased from ¥41.947 million in the previous year to ¥41.496 million. - FY2026-H1Increase in R&D ExpenditureAnnual report
「The amount spent on research and development activities across the Group during the six-month consolidated accounting period was ¥15 million.」
While maintaining the explanation that there were no material changes in research and development activities, the amount spent on research and development activities increased from ¥13 million in the same period of the previous year to ¥15 million. - FY2025Increase in R&D ExpenditureAnnual report
「The total amount of research and development expenses for the consolidated fiscal year was ¥41.947 million.」
Research and development activities continued, and research and development expenses increased from ¥22.396 million in the previous year to ¥41.947 million. - FY2025-H1Increase in R&D ExpenditureAnnual report
「The amount spent on research and development activities across the Group during the six-month consolidated accounting period was ¥13 million.」
While maintaining the explanation that there were no material changes in the status of research and development activities, the amount spent on research and development activities increased from ¥9 million in the same period of the previous year to ¥13 million. - FY2024R&D expenses decreasedAnnual report
「The total amount of research and development expenses for the consolidated fiscal year was ¥22.396 million.」
Research and development activities continued, but research and development expenses decreased from ¥25.940 million in the previous year to ¥22.396 million. - FY2024-Q3R&D expenses decreasedAnnual report
「The group-wide amount spent on research and development activities during the cumulative third quarter was ¥14 million. There were no material changes in the status of the group's research and development activities during the cumulative third quarter.」
Although the explanation that there were no material changes in the status of research and development activities was maintained, research and development expenses decreased from ¥21 million in the same period of the previous year to ¥14 million. - FY2024-Q2Increase in R&D ExpenditureAnnual report
「The amount spent on research and development activities across the Group during the six-month period ended [current second quarter] was ¥9 million. There were no material changes in the status of the Group’s research and development activities during the period.」
While maintaining the explanation that there were no material changes in the status of research and development activities, the amount spent on research and development activities increased from ¥7 million in the same period of the previous year to ¥9 million. - FY2024-Q1R&D expenses decreasedAnnual report
「The Group's total research and development activities during the three-month period ended the first quarter amounted to ¥4 million. There were no material changes in the status of the Group's research and development activities during the three-month period ended the first quarter.」
Although the explanation that there were no material changes in the status of research and development activities continued, the amount spent on research and development activities decreased from ¥7 million in the same period of the previous year to ¥4 million. - FY2023R&D expenses decreasedAnnual report
「The total amount of research and development expenses for the consolidated fiscal year was ¥25.940 million.」
Research and development activities continued, but research and development expenses decreased from ¥36.984 million in the same period of the previous year to ¥25.940 million. - FY2023-Q3Increase in R&D ExpenditureAnnual report
「The amount spent on research and development activities across the Group during the nine-month period ended [current third quarter] was ¥21 million. There were no material changes in the status of the Group’s research and development activities during the period.」
While maintaining the explanation that there were no material changes in the status of research and development activities, research and development expenses increased from ¥13 million in the same period of the previous year to ¥21 million. - FY2023-Q2Increase in R&D ExpenditureAnnual report
「The amount spent on research and development activities across the Group during the six-month period ended [current second quarter] was ¥13 million.」
Although the explanation that there were no material changes in the status of research and development activities continued, the amount spent on research and development activities increased from ¥6 million in the same period of the previous year to ¥13 million. - FY2023-Q1Increase in R&D ExpenditureAnnual report
「Group-wide research and development expenditure for the three-month period ended with the first quarter of the current fiscal year was ¥7 million.」
The explanation that there were no material changes in the status of research and development activities continued, and the amount spent on research and development activities increased from ¥6 million in the same period of the previous year to ¥7 million. - FY2022-Q3Increase in R&D ExpenditureAnnual report
「The amount spent on research and development activities across the Group during the nine-month period ended [current third quarter] was ¥27 million.」
Although the explanation that there were no material changes in research and development activities continued, the amount spent on research and development activities increased from ¥13 million in the same period of the previous year to ¥27 million. - FY2022-Q2Increase in R&D ExpenditureAnnual report
「The amount spent on R&D activities by the Group as a whole during the first six months of the current consolidated fiscal year was ¥17 million. There were no material changes in the status of the Group's R&D activities during the first six months of the current consolidated fiscal year.」
Although the explanation that there were no material changes in the status of research and development activities continued, the amount spent on research and development activities increased from ¥6 million in the previous quarter to ¥17 million. - FY2022-Q1RestatedAnnual report
「The Group's total research and development activities during the three-month period ended the first quarter amounted to ¥6 million. There were no material changes in the status of the Group's research and development activities during the three-month period ended the first quarter.」
The explanation that there were no material changes in research and development activities continued, and research and development expenses were reported at ¥6 million. - FY2021Increase in R&D ExpenditureAnnual report
「The total amount of research and development expenses for the consolidated fiscal year was ¥19.537 million.」
While the explanation that there were no material changes in research and development activities continued, research and development expenses increased from ¥14.092 million in the previous year to ¥19.537 million. - FY2021-Q3RestatedAnnual report
「The Group's total research and development activities during the nine-month period ended the third quarter amounted to ¥13 million. There were no material changes in the status of the Group's research and development activities during the nine-month period ended the third quarter.」
The explanation that there were no material changes in the status of research and development activities continued. The amount spent on research and development activities was ¥13 million. - FY2021-Q2RestatedAnnual report
「The amount spent on research and development activities across the Group during the six-month period ended [current second quarter] was ¥6 million. There were no material changes in the status of the Group’s research and development activities during the period.」
The explanation that there were no material changes in research and development activities continued, and cumulative research and development expenses were reported at ¥6 million. - FY2021-Q1Research and development expenses fell sharplyAnnual report
「Group-wide R&D expenses for the first quarter of the current consolidated cumulative period amounted to ¥1 million. There were no material changes in the status of the Group's R&D activities during the period.」
Although the explanation that there were no material changes in research and development activities continued, the amount spent on research and development activities decreased from ¥9.016 million in the same period of the previous year to ¥1 million. - FY2020R&D expenses decreasedAnnual report
「The total amount of research and development expenses for the consolidated fiscal year was ¥14.092 million.」
Although the explanation that there were no material changes in research and development activities continued, research and development expenses decreased from ¥35.187 million in the same period of the previous year to ¥14.092 million. - FY2020-Q3RestatedAnnual report
「The amount spent on research and development activities across the Group during the nine-month period ended [current third quarter] was ¥10 million. There were no material changes in the status of the Group’s research and development activities during the period.」
The explanation that there were no material changes in research and development activities continued. - FY2020-Q2RestatedAnnual report
「The amount spent on research and development activities across the Group during the six-month period ended [current second quarter] was ¥6 million. There were no material changes in the status of the Group’s research and development activities during the period.」
The explanation that there were no material changes in research and development activities continued. - FY2019-Q3RestatedAnnual report
「The Group's total R&D activity expenses for the cumulative third quarter were ¥28 million. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter.」
The explanation that there were no material changes in research and development activities continued. Research and development spending amounted to ¥28 million. - FY2019-Q2RestatedAnnual report
「The amount spent on research and development activities across the Group during the six-month period ended [current second quarter] was ¥17.044 million. There were no material changes in the status of the Group’s research and development activities during the period.」
The explanation that there were no material changes in research and development activities continued. - FY2019-Q1RestatedAnnual report
「The amount spent on research and development activities across the Group during the three-month period ended [current first quarter] was ¥9.016 million. There were no material changes in the status of the Group’s research and development activities during the period.」
The explanation that there were no material changes in research and development activities continued. Research and development spending for the quarter was ¥9.016 million. - FY2018RestatedAnnual report
「The total amount of research and development expenses for the consolidated fiscal year was ¥51.478 million.」
The policy of continuing research and development activities was maintained, and full-year research and development expenses amounted to ¥51.478 million. - FY2018-Q3RestatedAnnual report
「The amount spent on research and development activities across the Group during the nine-month period ended [current third quarter] was ¥40.998 million. There were no material changes in the status of the Group’s research and development activities during the period.」
The explanation that there were no material changes in research and development activities continued, with cumulative research and development spending reported at ¥40.998 million. - FY2018-Q2RestatedAnnual report
「The Group's total research and development expenditure for the first six months of the current fiscal year was ¥27.349 million. In addition, there were no significant changes in the status of the Group's research and development activities during the first six months of the current fiscal year.」
The explanation that there were no significant changes in research and development activities continued. Research and development expenditure was ¥27.349 million. - FY2018-Q1RestatedAnnual report
「The Group's total research and development expenditure for the first quarter of the current fiscal year was ¥12.971 million. In addition, there were no significant changes in the status of the Group's research and development activities during the first quarter of the current fiscal year.」
The policy of reporting no significant changes in research and development activities continued, and research and development expenditure for the quarter was reported. - FY2017RestatedAnnual report
「Total research and development expenditure for the current fiscal year was ¥35.910 million.」
Research and development activities continued, with full-year research and development expenditure reported at ¥35.910 million. - FY2017-Q3RestatedAnnual report
「There were no significant changes in the issues to be addressed by the Group during the first nine months of the current fiscal year. In addition, the Group's total research and development expenditure for the first nine months of the current fiscal year was ¥25.373 million. There were also no significant changes in the status of the Group's research and development activities during the first nine months of the current fiscal year.」
It states that there were no significant changes in the issues to be addressed or in the status of research and development activities, and reports research and development expenditure of ¥25.373 million. - FY2017-Q2RestatedAnnual report
「There were no significant changes in the issues to be addressed by the Group during the first six months of the current fiscal year. In addition, the Group's total research and development expenditure for the first six months of the current fiscal year was ¥17.205 million. There were also no significant changes in the status of the Group's research and development activities during the first six months of the current fiscal year.」
It states that there were no significant changes in the issues to be addressed or in the status of research and development activities, and reports research and development expenditure of ¥17.205 million. - FY2017-Q1First statedAnnual report
「There were no significant changes in the issues to be addressed by the Group during the first quarter of the current fiscal year. In addition, there were no significant changes in the status of the Group's research and development activities during the first quarter of the current fiscal year.」
It states that there were no significant changes in the issues to be addressed or in research and development activities.